Mountain View, Calif.
Went public 8/9/2000 at $10 per share
Filing Range: 3.75 mil. shares @ $12 to $14
Shares Outstanding: 18.492 mil. shares
Underwriters: Donaldson, Lufkin & Jenrette/Chase H&Q/Wit SoundView
Group Inc./DLJdirect Inc.
Company Counsel: Cooley Godward LLP
Manager Counsel: Sullivan & Cromwell
Auditor: Ernst & Young LLP
The Company:
Develops software tools to accelerate clinical trials and software for pharmaceuticals companies.
Venture Backers:
Weiss, Peck & Greer Venture Partners LP
Asset Management Associates Inc.
Sprout Group
Solstice Capital
Needham & Co. Inc.
McKesson Corp.
DLJ Capital
Financing Rounds:
Number ofRound Amt.
Round # Round Date Stage Investors ($ thousands)
1 01/01/1996 2 Early Stage 1425.0
2 07/01/1996 2 Expansion 800.0
3 04/01/1997 6 Expansion 6000.0
4 06/01/1998 2 Expansion 2000.0
5 07/01/1998 4 Expansion 7000.1
6 11/15/1998 8 Expansion 9000.0
7 09/16/1999 7 Expansion 20099.8
Financials:
(Data in $ millions)
Y/E
3/31/00
Total Revenues: $8.9
Net Income: -10.0